Stay updated on Long-Term BMN 190 in CLN2 Disease Clinical Trial
Sign up to get notified when there's something new on the Long-Term BMN 190 in CLN2 Disease Clinical Trial page.
Latest updates to the Long-Term BMN 190 in CLN2 Disease Clinical Trial page
- Check6 days agoChange DetectedThe revision label on the page updated from v3.3.3 to v3.3.4. No other content or study details appear to be changed.SummaryDifference0.1%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Locations section including Ohio and Piazza; removed HHS Vulnerability Disclosure and Piazza Locations; updated page revision to v3.3.3.SummaryDifference0.3%
- Check49 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.1%
- Check56 days agoChange DetectedThe Publications section text was updated to note that entries are automatically filled from PubMed and may not all pertain to the study, and the revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check64 days agoChange DetectedRemoved the government funding lapse notice from the page. The overall study details, eligibility, and locations are unchanged.SummaryDifference0.4%
- Check78 days agoChange DetectedThe changes are formatting and layout adjustments on the Study Details page, while the study content and data remain unchanged.SummaryDifference0.4%
Stay in the know with updates to Long-Term BMN 190 in CLN2 Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term BMN 190 in CLN2 Disease Clinical Trial page.